Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Development of a Low-Cost, Point-of-Care Bilirubin Measurement Device to Diagnose Neonatal Jaundice and Monitor Phototherapy in Low Resource Settings

Our idea is to develop BiliSpec, a bilirubin monitoring device with a per-test cost of less than $0.10. BiliSpec includes: (1) a lateral-flow device to separate serum from whole blood in under 30 seconds and (2) a battery powered reader to measure light transmission through the separated serum on the strip and display the bilirubin concentration. We estimate our device could prevent the deaths of approximately ninety-thousand neonates who die every year due to lack of access to effective treatment and monitoring for neonatal jaundice in low-resource settings.

More information about Saving Lives at Birth (Round 5)